[Role of myocardium scintigraphy with thallium dipyridamole in the evaluation of arterial disease of the legs].
Thirty-eight consecutive patients with severe arterial disease of the lower extremities benefited from an exploration of the coronary reserve by myocardial scintigraphy with thallium dipyridamole. With this examination, it has been possible to screen 20 p. cent of asymptomatic patients and at least modify the perioperative treatment or even the very indication for surgery.
Vitoux
J F
JF
Centre de Recherche Claude-Bernard sur les Maladies vasculaires périphériques, Hôpital Broussais, Paris.
Languillat
N
N
du Peloux
L
L
Lévy
M
M
Fiessinger
J N
JN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging*; D001161:Arteriosclerosis / Q000000981:diagnostic imaging*; D004176:Dipyridamole; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization; D011877:Radionuclide Imaging; D013794:Thallium Radioisotopes
D013794:Thallium Radioisotopes; D004176:Dipyridamole
La place de la scintigraphie myocardique au thallium dipyridamole dans le bilan de l'artériopathie des membres inférieurs.